Decreased interferon-β induced STAT-4 activation in immune cells and clinical outcome in multiple sclerosisTools Tanasescu, Radu, Midgley, Angela, Robins, R. Adrian and Constantinescu, Cris S. (2016) Decreased interferon-β induced STAT-4 activation in immune cells and clinical outcome in multiple sclerosis. Acta Neurologica Scandinavica . ISSN 1600-0404 Full text not available from this repository.AbstractObjectives. Interferon-β (IFN-β) is used in the treatment of multiple sclerosis (MS). IFN-β activation of signal transduction and activation of transcription (STAT)-4 is linked to its immunomodulatory effects. Previous studies suggest a type I IFN deficit in immune cells of MS patients, but data on interferon-α/β receptor (IFNAR) expression and the relationship with treatment response are conflicting. Here we compare IFN-β-mediated STAT4 activation in immune cells of untreated MS patients and controls.
Actions (Archive Staff Only)
|